A Study of LY3832479 (LY-CoV016) in Healthy Participants

NCT04441931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3832479
DRUG: Placebo

Sponsor

Eli Lilly and Company